Is TRT Safe? What the Research Says About Heart and Prostate Risk
Testosterone shots, gels and patches can improve symptoms of confirmed low T, yet the therapy carries real risks that every man should weigh. Here is the evidence behind cardiovascular, prostate and blood-clot safety-and how doctors monitor treatment to keep it as safe as possible.
Testosterone replacement therapy (TRT) is generally safe for men who truly need it and who are properly monitored, according to major medical societies and U.S. Food and Drug Administration guidance. The most consistent risks are a rise in red-blood-cell concentration (polycythemia), mild prostate growth and rare blood clots; large trials have not shown a clear increase in heart attacks or strokes when men are screened and doses are kept within physiologic ranges. Regular lab work-including hematocrit, prostate-specific antigen (PSA) and testosterone levels-allows providers to stop or adjust therapy before a serious problem develops.
- The FDA requires a boxed warning that testosterone can raise blood pressure and increase the risk of blood clots in the veins (fda.gov).
- Endocrine Society guidelines advise checking hematocrit at baseline, 3 months and yearly, stopping TRT if it exceeds 54% (endocrine.org).
- Prostate-specific antigen should be measured before starting and again at 3-12 months; a rise greater than 1.4 ng/mL merits a urology referral (AUA).
- TRT improved bone-mineral density in clinical trials of men with hypogonadism, with no fracture signal so far (Tenuta et al., 2025) (Rochira, 2020).
- Men with untreated prostate cancer, uncontrolled sleep apnea, or a recent heart attack or stroke should not start TRT (fda.gov).
What Testosterone Replacement Therapy Is-And How It Works
TRT is a prescription treatment that raises blood testosterone into the normal adult male range to relieve symptoms of hypogonadism. Options include intramuscular injections such as testosterone cypionate (the most widely used form), gels applied to the skin, patches worn for 24 hours and less-common nasal or oral formulations.
Injectable testosterone replaces the hormone that the testes can no longer produce in adequate amounts, restoring anabolic and metabolic effects that support libido, energy, red-blood-cell production and bone density (Tenuta et al., 2025). The FDA approves TRT only for men with both consistent symptoms and two early-morning total testosterone levels below about 300 ng/dL (fda.gov).
TRT from Rx.com is launching soon: licensed U.S. providers will review your symptoms, order the necessary tests and, if appropriate, prescribe testosterone cypionate shipped to your door.
How TRT Affects the Heart
Evidence so far shows no definitive link between testosterone therapy and major cardiovascular events when men are carefully selected and monitored. Early observational studies hinted at higher heart-attack rates, prompting the FDA to add a warning in 2015 (fda.gov).
Possible mechanisms: testosterone can increase red-blood-cell mass, slightly thicken blood and, at supraphysiologic doses, may raise blood pressure. Conversely, normalizing low T often reduces fat mass and insulin resistance, factors that lower heart risk.
Large placebo-controlled trials have not confirmed a significant rise in heart attack or stroke when testosterone levels stay within the physiologic range, but they have highlighted smaller signals: more atrial fibrillation and pulmonary embolism episodes were reported in the testosterone groups of several studies (nejm.org). Because the absolute event numbers were low, regulators call for continued surveillance.
| Cardiovascular marker | Typical change on TRT | Action threshold |
|---|---|---|
| Hematocrit | ↑ 2-5 percentage points within 3 months | Stop or lower dose at ≥54% |
| Blood pressure | ↑ 2-3 mm Hg systolic average | Persistent ≥140/90 mm Hg despite treatment |
| HDL cholesterol | ↓ 2-5 mg/dL on injectable forms | Evaluate if HDL <40 mg/dL |
Does TRT Raise Prostate Cancer Risk?
Current data do not show that physiologic testosterone replacement causes prostate cancer, but it can accelerate growth of an existing tumor. The FDA label lists known or suspected prostate cancer as a contraindication (fda.gov).
Why the concern exists: prostate tissue is androgen sensitive and will enlarge in response to higher testosterone. Benign prostatic hyperplasia (BPH) symptoms-frequent urination, weak stream-often worsen slightly in the first year of therapy.
Most longitudinal studies have found no significant increase in prostate-cancer incidence among TRT users compared with untreated men of similar age. Still, clinicians measure PSA and conduct a digital rectal exam before starting therapy and repeat PSA within 3-12 months. A PSA rise greater than 1.4 ng/mL in one year or an absolute PSA above 4 ng/mL usually triggers a urology referral.
Considering testosterone therapy?
See if online TRT through Rx.com will be right for you when it launches.
Blood-Clot and Stroke Concerns
Testosterone is associated with a small but measurable increase in venous thromboembolism (VTE) events such as deep-vein thrombosis and pulmonary embolism. The FDA added a VTE warning to all testosterone products in 2014 (fda.gov).
Two main pathways are proposed: higher hematocrit makes blood more viscous, and testosterone may increase platelet aggregation. The absolute risk remains low-estimated at roughly 3 additional VTE cases per 10,000 person-years in some observational cohorts-but applies even within the first few months of therapy.
Men with known thrombophilia, prior unprovoked VTE or recent orthopedic surgery should generally avoid starting TRT until fully evaluated.
| Form of TRT | Typical dose range (FDA label) | Peak hematocrit change |
|---|---|---|
| Testosterone cypionate injection | 50-400 mg every 2-4 weeks | +3-7 percentage points |
| Transdermal gel (1%) | 50-100 mg daily | +1-3 points |
| 24-h patch | 4-6 mg daily | +1-2 points |
Who Should Avoid or Delay TRT
TRT is not appropriate for every man complaining of low energy or libido. The Endocrine Society, American Urological Association and FDA align on several red-flag situations:
Absolute contraindications: metastatic or high-risk prostate cancer, male breast cancer, hematocrit ≥54%, poorly controlled heart failure, severe untreated sleep apnea, recent myocardial infarction or stroke (within 6 months) and desire for fertility in the near term (testosterone suppresses sperm production).
Relative contraindications: symptomatic BPH, baseline PSA >4 ng/mL, uncontrolled hypertension, thrombophilia, or a strong family history of prostate cancer diagnosed before age 45.
If any of the above applies to you, discuss alternative treatments such as selective estrogen-receptor modulators or treat contributing conditions first. Our guide how telehealth treats low testosterone explains the diagnostic process in detail.
Should I ask my doctor about TRT now?
Check the column that fits your situation:
✅ Probably a good candidate
- Two early-morning testosterone values below 300 ng/dL
- Persistent symptoms (low libido, fatigue, low mood)
- PSA within age-specific normal range
- Hematocrit below 50%
- No plans for children in the next 1-2 years
🏥 Needs specialist review first
- History of prostate or breast cancer
- Heart attack, stroke or PE within 6 months
- Hematocrit ≥54% or untreated sleep apnea
- Baseline PSA >4 ng/mL or rapid PSA rise
- Current fertility pursuit or severe infertility
How Providers Monitor TRT for Safety
Regular blood tests and symptom check-ins are the cornerstone of safe therapy. Below is the schedule most Endocrine Society guideline-based clinics follow; your provider may adjust it for your health profile.
| Parameter | Baseline | First follow-up | Ongoing | Action threshold |
|---|---|---|---|---|
| Total testosterone | 2 tests, AM | 3 months | 6-12 months | Adjust dose if level <350 or >1,000 ng/dL |
| Hematocrit | Yes | 3 months | Every 12 months | Stop or pause ≥54% |
| PSA (men >40 yr) | Yes | 3-12 months | Yearly | Rise >1.4 ng/mL/yr or PSA >4 ng/mL |
| Lipid panel | Yes | 6 months | Yearly | LDL ≥190 mg/dL: treat per guidelines |
| Blood pressure | Yes | Each visit | Each visit | Uncontrolled ≥140/90 mm Hg |
Lab convenience: Many telehealth TRT programs send you to a local lab for blood draws, and injections are done at home, so you do not need clinic visits for shots. Learn more in our high-hematocrit TRT guide.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Sudden chest pain or pressure: could signal a heart attack or pulmonary embolism
- Shortness of breath at rest: may indicate a blood clot in the lungs
- One-sided leg swelling or pain: possible deep-vein thrombosis
- Severe headaches or vision changes: can accompany dangerously high blood pressure
- Rapid increase in urination or difficulty starting flow: may mean prostate enlargement
- Dark or bloody urine: needs evaluation for prostate or kidney issues
- Mood changes, depression or irritability: mental-health side effects can occur
- Allergic reaction to an injection: hives, throat swelling, dizziness
Scientific References
- Tenuta M, Hasenmajer V, Gianfrilli D, et al. Testosterone and Male Bone Health: A Puzzle of Interactions. J Clin Endocrinol Metab. 2025.
- Rochira V. Late-onset Hypogonadism: Bone health. Andrology. 2020.
- Smith SJ, Lopresti AL, Teo SYM, et al. Examining the Effects of Herbs on Testosterone Concentrations in Men: A Systematic Review. Adv Nutr. 2021.
- U.S. Food and Drug Administration. fda.gov.
- Endocrine.org | Endocrine Society. endocrine.org.
- AUA: Home, American Urological Association. auanet.org.
- Just a moment. nejm.org.
Frequently Asked Questions
Is TRT safe long term?
Safety data beyond 5 years are limited, but studies up to that point show stable cardiovascular and prostate profiles when men are closely monitored. Annual labs and regular provider visits remain essential.
Does TRT cause infertility?
Yes. External testosterone suppresses the pituitary signals that drive sperm production, which can lower or even stop sperm counts. Men who want children in the next couple of years should ask about alternatives such as clomiphene or hCG.
Can I take testosterone and finasteride together?
Finasteride blocks conversion of testosterone to dihydrotestosterone (DHT) and is sometimes used to limit hair loss on TRT. This combination is generally safe but should be coordinated with your provider and monitored for prostate effects.
Will insurance pay for my labs on TRT?
Many commercial plans cover guideline-recommended monitoring, but deductibles apply. If you pay cash, ask the lab for its self-pay price before your draw; prices vary widely between labs.
How soon will I feel better on TRT?
Libido and energy often improve in 3-6 weeks, while body-composition and bone-density changes can take 3-6 months. If you notice no benefit by 6 months, talk to your provider about adjusting the dose or re-evaluating the diagnosis.
Can herbs replace testosterone therapy?
Herbal supplements like fenugreek and ashwagandha may boost testosterone slightly in some studies, but the increases are modest and inconsistent (Smith et al., 2021). They are not considered substitutes for prescription TRT in men with proven hypogonadism.
Does TRT help bone health?
Yes. Multiple trials show that TRT increases lumbar-spine and hip bone-mineral density in hypogonadal men, although a fracture-prevention benefit has not been proven (Tenuta et al., 2025) (Rochira, 2020).
Ready to explore testosterone treatment?
See if you qualify for online TRT with U.S.-licensed providers when Rx.com launches, and lock in early access to convenient at-home care.
